ACE (angiotensin I converting enzyme) is a metallopeptidase that functions as a key regulatory enzyme in the renin-angiotensin system with significant implications for cardiovascular physiology and human performance. The gene exhibits an insertion/deletion (I/D) polymorphism that substantially impacts human physical performance, with the I allele consistently associated with endurance-oriented activities and the D allele linked to strength- and power-oriented performance 1. Meta-analysis confirms that individuals with the ACE II genotype have a significantly higher likelihood of being endurance athletes compared to controls 2. At the molecular level, ACE forms functional complexes with bradykinin B2 receptors at the plasma membrane, where ACE inhibitors enhance bradykinin actions through mechanisms independent of blocking bradykinin degradation 3. The enzyme also interacts with other components of the renin-angiotensin system, including ACE2, where therapeutic agents like thymosin-α1 can bind ACE and modulate ACE2 expression in respiratory epithelia 4. Population studies reveal significant genetic diversity in ACE polymorphisms across different ethnic groups, with implications for susceptibility to infectious diseases including COVID-19 and malaria 5. Additionally, ACE expression varies in reproductive tissues, though ACE inhibitors do not significantly affect endometrial receptivity for embryo implantation 6.